Suppr超能文献

病毒干扰素调节因子对p53肿瘤抑制因子的抑制作用

Inhibition of p53 tumor suppressor by viral interferon regulatory factor.

作者信息

Nakamura H, Li M, Zarycki J, Jung J U

机构信息

Department of Microbiology and Molecular Genetics, Tumor Virology Division, New England Regional Primate Research Center, Harvard Medical School, Southborough, Massachusetts 01772, USA.

出版信息

J Virol. 2001 Aug;75(16):7572-82. doi: 10.1128/JVI.75.16.7572-7582.2001.

Abstract

The irreversible cell cycle arrest and apoptosis induced by p53 are part of the host surveillance mechanisms for viral infection and tumor induction. Kaposi's sarcoma-associated herpesvirus (KSHV), the most recently discovered human tumor virus, is associated with the pathogenesis of Kaposi's sarcoma, primary effusion lymphoma, and multicentric Castleman's disease. The K9 open reading frame of KSHV encodes a viral interferon (IFN) regulatory factor (vIRF) which functions as a repressor for cellular IFN-mediated signal transduction and as an oncoprotein to induce cell growth transformation. Here, we demonstrate that KSHV vIRF interacts with the cellular p53 tumor suppressor through the putative DNA binding region of vIRF and the central region of p53. This interaction suppresses the level of phosphorylation and acetylation of p53 and inhibits transcriptional activation of p53. As a consequence, vIRF efficiently prevents p53-mediated apoptosis. These results suggest that KSHV vIRF interacts with and inhibits the p53 tumor suppressor to circumvent host growth surveillance and to facilitate uncontrolled cell proliferation.

摘要

由p53诱导的不可逆细胞周期停滞和凋亡是宿主针对病毒感染和肿瘤诱发的监测机制的一部分。卡波西肉瘤相关疱疹病毒(KSHV)是最近发现的人类肿瘤病毒,与卡波西肉瘤、原发性渗出性淋巴瘤和多中心Castleman病的发病机制相关。KSHV的K9开放阅读框编码一种病毒干扰素(IFN)调节因子(vIRF),其作为细胞IFN介导的信号转导的抑制因子以及诱导细胞生长转化的癌蛋白发挥作用。在此,我们证明KSHV vIRF通过vIRF的假定DNA结合区域和p53的中央区域与细胞p53肿瘤抑制因子相互作用。这种相互作用抑制了p53的磷酸化和乙酰化水平,并抑制了p53的转录激活。结果,vIRF有效地阻止了p53介导的凋亡。这些结果表明,KSHV vIRF与p53肿瘤抑制因子相互作用并对其进行抑制,以规避宿主生长监测并促进不受控制的细胞增殖。

相似文献

1
Inhibition of p53 tumor suppressor by viral interferon regulatory factor.
J Virol. 2001 Aug;75(16):7572-82. doi: 10.1128/JVI.75.16.7572-7582.2001.
7
Inhibition of p300 histone acetyltransferase by viral interferon regulatory factor.
Mol Cell Biol. 2000 Nov;20(21):8254-63. doi: 10.1128/MCB.20.21.8254-8263.2000.
8
KSHV ORF K9 (vIRF) is an oncogene which inhibits the interferon signaling pathway.
Oncogene. 1997 Oct 16;15(16):1979-85. doi: 10.1038/sj.onc.1201571.
10
Kaposi's sarcoma-associated herpesvirus-encoded vIRF-3 stimulates the transcriptional activity of cellular IRF-3 and IRF-7.
J Biol Chem. 2004 Feb 27;279(9):7643-54. doi: 10.1074/jbc.M309485200. Epub 2003 Dec 10.

引用本文的文献

2
HIV-associated cancers and lymphoproliferative disorders caused by Kaposi sarcoma herpesvirus and Epstein-Barr virus.
Clin Microbiol Rev. 2024 Sep 12;37(3):e0002223. doi: 10.1128/cmr.00022-23. Epub 2024 Jun 20.
5
The ORF45 Protein of Kaposi Sarcoma-Associated Herpesvirus Is an Inhibitor of p53 Signaling during Viral Reactivation.
J Virol. 2021 Nov 9;95(23):e0145921. doi: 10.1128/JVI.01459-21. Epub 2021 Sep 15.
6
Metabolic Control by DNA Tumor Virus-Encoded Proteins.
Pathogens. 2021 May 6;10(5):560. doi: 10.3390/pathogens10050560.
7
Proteomic approaches to investigate gammaherpesvirus biology and associated tumorigenesis.
Adv Virus Res. 2021;109:201-254. doi: 10.1016/bs.aivir.2020.10.001. Epub 2020 Nov 9.
9
The roles of signaling pathways in SARS-CoV-2 infection; lessons learned from SARS-CoV and MERS-CoV.
Arch Virol. 2021 Mar;166(3):675-696. doi: 10.1007/s00705-021-04958-7. Epub 2021 Jan 18.
10
Molecular Virology of KSHV in the Lymphocyte Compartment-Insights From Patient Samples and Infection Models.
Front Cell Infect Microbiol. 2020 Dec 4;10:607663. doi: 10.3389/fcimb.2020.607663. eCollection 2020.

本文引用的文献

1
Surfing the p53 network.
Nature. 2000 Nov 16;408(6810):307-10. doi: 10.1038/35042675.
2
Inhibition of p300 histone acetyltransferase by viral interferon regulatory factor.
Mol Cell Biol. 2000 Nov;20(21):8254-63. doi: 10.1128/MCB.20.21.8254-8263.2000.
3
Adenovirus E1B 55-kilodalton oncoprotein inhibits p53 acetylation by PCAF.
Mol Cell Biol. 2000 Aug;20(15):5540-53. doi: 10.1128/MCB.20.15.5540-5553.2000.
6
Mutant p53: gain-of-function oncoproteins and wild-type p53 inactivators.
Biol Chem. 1999 Jul-Aug;380(7-8):879-87. doi: 10.1515/BC.1999.108.
8
The p53 paradox in the pathogenesis of tumor progression.
Med Hypotheses. 1999 May;52(5):483-5. doi: 10.1054/mehy.1998.0741.
9
The p53 pathway.
J Pathol. 1999 Jan;187(1):112-26. doi: 10.1002/(SICI)1096-9896(199901)187:1<112::AID-PATH250>3.0.CO;2-3.
10
Covalent and noncovalent modifiers of the p53 protein.
Cell Mol Life Sci. 1999 Jan;55(1):76-87. doi: 10.1007/s000180050271.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验